The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.

The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu ...

Moderna received a refusal-to-file letter from the FDA objecting to how it conducted a 40,000-person trial comparing its new ...

By Sneha S K Feb 10 (Reuters) - The U.S. Food and Drug Administration will not review Moderna's approval application for its ...

For those considering graduate school, the application process can seem overwhelming. What should be included in a statement of purpose? What programs should be explored? Who should write letters of ...

The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.

News is latest sign of the agency's heightened scrutiny of vaccines ...

The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma ...

February is when scholarship deadlines get real. A tracker turns scattered portals, PDFs, and emails into one list with clear ...

The news is the latest sign of the FDA’s heightened scrutiny of vaccines under Health Secretary Robert F. Kennedy Jr.